Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Efficacy of chemotherapy treatments compared
September 29th, 2005
The efficacy of chemotherapy treatments was compared in a recent investigation in Canada. "Certain anthracycline-containing adjuvant chemotherapy regimens are associated with improved relapse-free survival (RFS) and overall survival (OS) compared with the classic regimen of cyclophosphamide, methotrexate, and fluorouracil in women with early-stage breast cancer," according to scientists in Canada. The study designed was described by M. N. Levine and colleagues: "Between 1989 and 1993, 710 pre-and perimenopausal women with axillary node-positive breast cancer were randomly assigned to either cyclophosphamide 75 mg/m2 orally days 1 through...
Source: Women's Health Weekly (2005-09-29)
|
